Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
2175-A FACTORS ASSOCIATED WITH ADVANCED LIVER FIBROSIS IN A POPULATION WITH TYPE 2 DIABETES: A 5-YEARS RETROSPECTIVE COHORT STUDY IN MEXICO CITY Zeltzin Soto Montes 1 , Maria Juliana Corredor-Nassar 1 , Froylan David Martinez-Sanchez 2 , David Medina-Julio 1 , Carolina Martinez-Perez 1 , Gibran Gonzalez-Alvarez 1 , Victor Manuel Paz-Zarza 1 , Sandra Milena Feria-Agudelo 1 , Alejandra Diaz-Jarquin 1 , Omhariany Medina-Garza 1 , Erika Karina Tenorio-Aguirre 2 and Jacqueline Cordova Gallardo 3 , (1)Hospital General Manuel Gea Gonzalez, (2)Hospital General Manuel Gea Gonzlez, (3)Hospital General Manuel Gea Gonz Background: Metabolic-associated fatty liver disease (MAFLD) is a major cause of liver related morbidity and mortality worldwide
Understanding how fatigue differs between GLP-1 medications can also inform whether the issue is medication-specific or class-wide
Pleasant, SC 29464 Call us at 843.375.2215
It also supports healthy heart, skeletal, and liver function, as these tissues rely on fatty acid oxidation as for energy
